Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic, Robert J. Cardnell, Lixia Diao, Kavya Ramkumar, Carl M. Gay, C. Allison Stewart, You-Hong Fan, Li Shen,

Journal of Thoracic Oncology · 2019 · 119 citations · 20 references

DOIFull text

Open access

Concepts

References

20